AptaBio
South Korea · Founded 2009
- Employees
- 11–50
- Founded
- 2009
- Business Model
- B2B
- Website
- aptabio.com
About
AptaBio Therapeutics is a Korean biopharmaceutical company founded in 2009, specializing in platform-based First-in-Class drug development for intractable diseases including diabetic complications, vascular disease, neurodegenerative disorders, and cancer. The company's core platforms target oxidative stress regulation (inflammation and fibrosis) and cancer-associated fibroblast (CAF) modulation to develop novel therapeutics with improved efficacy and reduced resistance. AptaBio is publicly listed on the Korean stock exchange and holds multiple patents in blood, pancreatic, and liver cancer therapies.
Summary
AptaBio is a Biotech company based in South Korea, founded in 2009.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aptabio"><img src="https://indexed.vc/api/badge/company/aptabio" alt="AptaBio on Indexed.vc" width="260" height="76" /></a>